(C) mRNA expression in mouse LCA (2 days post-ligation) was determined by qPCR (= 5)

(C) mRNA expression in mouse LCA (2 days post-ligation) was determined by qPCR (= 5). inhibits endothelial inflammation = 5, *= 6, *= 3). Images shown are representative microscopy images at 18 h. (B) VSMCs were cultured in 96-well plates for 24 h, serum-starved for 12 h, then treated with PDGF-BB (25 ng/mL; 24 h), and cell proliferation was determined by BrdU incorporation assay (= 5 each). (C-D) VSMCs from non-Tg mice were treated with rhIL-32 (25-100 ng/mL) for 24 h in serum-free medium, then cells were treated with PDGF-BB (25 ng/mL; 24 h). (C) cell migration (= 3) and (D) cell proliferation (= 5) were determined as described above (data shown as mean SEM, *MMP activity assays, cells were cultured in 96-well plates for 24 h, then treated with PDGF-BB (25 ng/mL; 24 h). MMP activity was determined by cell-based enzyme-linked immunosorbent assay (ELISA) using DQ?-gelatin (data shown as mean SEM; = 8, *= 3, *findings were relevant using hIL-32-Tg mice. Sulfo-NHS-Biotin First, we verified arterial hIL-32 expression in Tg mice with reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry. As expected, IL-32 mRNA and protein were clearly expressed in hIL-32-Tg mice arteries, particularly in the endothelial layer, but not in those from non-Tg littermate controls (Fig. ?(Fig.3A;3A; Supplementary Fig. 1). Rat monoclonal to CD4.The 4AM15 monoclonal reacts with the mouse CD4 molecule, a 55 kDa cell surface receptor. It is a member of the lg superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC classII and associating with the protein tyrosine kinase, lck Interestingly, we also found that basal VCAM-1 and ICAM-1 expression was lower in the aortas of hIL-32-Tg mice as compared to non-Tg counterparts (Figs. ?(Figs.33B-E). Open in a separate window Figure 3 Vascular adhesion protein expression is suppressed in the artery endothelium of transgenic hIL-32 (hIL-32-Tg) mice. (A-C) Thoracic aorta sections of hIL-32-Tg and littermate non-Tg control mice were immunohistochemically stained for (A) IL-32, (B) VCAM-1, and Sulfo-NHS-Biotin (C) ICAM-1. Images shown are representative Sulfo-NHS-Biotin microscopy images (= 3 each). The red rectangle indicates the magnified area shown in the lower panel. Nuclei (blue) and protein expression (brown) are shown. Scale bar, 100 m. Expression of (D) VCAM-1 and (E) ICAM-1 (red) in the endothelium was determined by immunofluorescence double-stained with a specific endothelium marker CD31 (cyan). Auto-fluorescence (yellow) shows internal elastic lamina (IEL). Nuclei were stained with DAPI (blue). The red rectangle indicates the magnified area shown in the lower panel. (F) VCAM-1 and ICAM-1 mRNA expression was determined by qPCR using endothelial-enriched RNA obtained from the left carotid artery (LCA) and right carotid artery (RCA) following partial carotid ligation in hIL-32-Tg or non-Tg mice Sulfo-NHS-Biotin at 2 days post-ligation (data shown as mean SEM; = 8, *= 6 each) were partially ligated and fed a high-fat diet for 4 weeks. (A) Aortic trees including the carotid arteries were dissected and examined by bright-field imaging. Scale bar, 1 mm. (B-C) Frozen sections prepared from the lesion area of LCA, denoted by red arrows in A, were stained for (B) alpha-smooth muscle actin (-SMA), a vascular smooth muscle cell marker, and (C) CD31, an endothelium marker. The red rectangle indicates the magnified area shown in the lower panel. Scale bar, 100 m. The thicknesses of the (D) intima media and (E) wall were quantified (data shown as mean SEM; = 6, *non-Tg RCA, (C) hIL-32-Tg LCA hIL-32-Tg RCA, (D) hIL-32-Tg RCA non-Tg RCA, and (E) hIL-32-Tg LCA non-Tg LCA after ligation. Genes are shown that were up-regulated (red) or down-regulated (blue) (2-fold difference) at a false discovery rate of 10% in LCA compared with RCA. Microarray results for selected (F) pro-atherogenic and (G) anti-atherogenic genes are shown as the fold-increase or fold-decrease of gene expression in hIL-32-Tg LCA compared with that in non-Tg LCA on a log2 scale (mean SEM). Sulfo-NHS-Biotin All genes shown in the graphs were significantly different between groups ((Fig. ?(Fig.6C;6C; Supplementary Fig..